Search

everythinglearnresearchcommunity

for

Search:↓

Some alternative treatments for hair loss might work, but more research is needed.

Consider benefits and risks of new alopecia treatments for safety.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

New grading scale accurately measures hair loss severity and treatment effectiveness.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Women with type D personality and PCOS experience more stress and use less effective coping strategies.

Androgenetic alopecia severity does not affect COVID-19 severity.

Patients and doctors often differ in assessing hair loss severity, so treatment should be personalized.

More severe hair loss worsens quality of life in men.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Hair thickness differences help diagnose hair loss severity.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

There's a significant link between severe hair loss and metabolic syndrome in Saudi Arabia, suggesting early health checks could prevent future issues.

Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Low PON1 levels may indicate and predict the severity of hair loss.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.